What is LOPJLB’s current signal on QNTM?

LOPJLB’s latest quantitative signal on Quantum BioPharma Ltd. (QNTM) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is QNTM in?

Quantum BioPharma Ltd. (QNTM) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Quantum BioPharma Ltd. (QNTM) do?

Quantum BioPharma Ltd., a biopharmaceutical firm headquartered in Toronto, Canada, is dedicated to the discovery and advancement of biotechnological solutions and drug candidates. The company focuses on addressing complex neurodegenerative, inflammatory, and metabolic conditions, alongside alcohol use disorder, with its pipeline featuring a range of drug candidates at varying stages of developm…

Quantum BioPharma Ltd. (QNTM)

COMPARE

Healthcare · Biotechnology · NASDAQ · CA

$2.89+2.48%Close

SELLCRISIS · day 9

Company news

defenseworld.net · 8d ago

Thermo Fisher Scientific (NYSE:TMO) Sets New 52-Week High – Time to Buy?

globenewswire.com · 8d ago

Quantum BioPharma Signs Contract with Thermo Fisher Scientific's Clinical Research Business to Implement Phase 2 Lucid-MS Trial in Multiple Sclerosis

globenewswire.com · 14d ago

IBN Announces Latest Episode of The BioMedWire Podcast Featuring the Return of Anthony Durkacz, Executive Co-Chair of Quantum BioPharma Ltd.

globenewswire.com · 20d ago

Quantum Biopharma Licensee Unbuzzd Wellness to Advance Clinically Validated Alcohol Metabolism Accelerant After Appointing Zappy as CEO

globenewswire.com · 27d ago

Rodman & Renshaw Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$8 Price Target

newsfilecorp.com · 29d ago

Quantum BioPharma to Attend the ArcStone-Kingswood Growth Summit 2026 in Toronto

globenewswire.com · 30d ago

NetworkNewsAudio Announces Audio Press Release (APR) Discussing FDA Clearance for Trial of First-in-Class Treatment Creating ‘Rare Moment' in MS Research

globenewswire.com · 33d ago

Quantum BioPharma Ltd. (NASDAQ: QNTM) Filling Key Gap in MS Treatment, Cleared by FDA to Launch Historic Trials

globenewswire.com · 35d ago

Quantum BioPharma Ltd. NASDAQ: QNTM) Receives FDA Clearance to Begin Trials for Historic MS Treatment

globenewswire.com · 42d ago

Quantum BioPharma Announces Plans to Voluntarily Delist its Class B Shares from the Canadian Securities Exchange

globenewswire.com · 53d ago

Quantum Biopharma Provides Corporate Update

globenewswire.com · 61d ago

Quantum BioPharma Strengthens Equity and Liquidity in Q2 2026 as FDA Approves Lucid-MS for Pivotal Phase 2 Clinical Trial

globenewswire.com · 65d ago

Quantum BioPharma Receives United States FDA Clearance To Proceed with Lucid-MS Phase 2 Trial in Progressive Multiple Sclerosis:

defenseworld.net · 70d ago

Quantum Biopharma (QNTM) Projected to Post Quarterly Earnings on Thursday

globenewswire.com · 76d ago

Quantum BioPharma Announces Closing of Debt Settlement

globenewswire.com · 85d ago

Quantum BioPharma Announces Intention to Settle Debt

globenewswire.com · 85d ago

Quantum BioPharma Announces Intention to Settle Debt

Market news & ticker search · RSS for QNTM

FAQ

What is LOPJLB’s current signal on QNTM?: LOPJLB’s latest quantitative signal on Quantum BioPharma Ltd. (QNTM) is SELL in a CRISIS regime. Signals are updated daily.
What market regime is QNTM in?: Quantum BioPharma Ltd. (QNTM) is currently classified in the CRISIS HMM market regime on LOPJLB.
What does Quantum BioPharma Ltd. (QNTM) do?: Quantum BioPharma Ltd., a biopharmaceutical firm headquartered in Toronto, Canada, is dedicated to the discovery and advancement of biotechnological solutions and drug candidates. The company focuses on addressing complex neurodegenerative, inflammatory, and metabolic conditions, alongside alcohol use disorder, with its pipeline featuring a range of drug candidates at varying stages of developm…

Quantum BioPharma Ltd. (QNTM)

Key stats

Prediction markets

Company news

FAQ